Loading market dashboard
Palisade Bio, Inc.
PALIHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Palisade Bio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $303.04M | $303.04M - $303.04M | $181.82M | $0.07 | 2 |
| Dec 2029 | $207.66M | $207.66M - $207.66M | $124.60M | -$0.28 | 2 |
| Dec 2028 | $81.03M | $81.03M - $81.03M | $48.62M | -$0.27 | 5 |
| Dec 2027 | $47.71M | $47.71M - $47.71M | $28.63M | -$0.24 | 6 |
| Dec 2026 | $27.87M | $27.87M - $27.87M | $16.72M | -$0.211 | 6 |
| Dec 2025 | $12.15M | $12.15M - $12.15M | $7.29M | -$0.544 | 6 |
| Dec 2024 | $8.21M | $8.21M - $8.21M | $4.93M | -$11.663 | 2 |
| Dec 2023 | $250.0K | $250.0K - $250.0K | $150.0K | -$28.145 | 2 |
| Dec 2022 | $250.0K | $250.0K - $250.0K | $150.0K | -$321.45 | 1 |
| Dec 2018 | $10.0K | $10.0K - $10.0K | $6.0K | -$2,620,800.00 | 1 |
| Dec 2017 | $10.0K | $10.0K - $10.0K | $6.0K | -$2,644,200.00 | 1 |
| Dec 2016 | $5.0K | $5.0K - $5.0K | $3.0K | -$216,450.00 | 1 |